Amarpreet Sawhney – Startup Investor Profile

Amarpreet Sawhney is the President and Chief Executive Officer of Ocular Therapeutix, Inc., focusing on ophthalmic surgical wound management and drug delivery. His investment focus area includes enterprises like Axtria. He has invested in Axtria during its Series A round with an investment amount of $2.5M. His professional career includes founding companies in the medical device industry, holding over 120 patents, and being named one of the ‘Five Most Innovative Medical Device CEOs’ in 2011. Amarpreet Sawhney has a Ph.D. and M.S. in Chemical Engineering and a B.Tech. in Chemical Engineering. His previous investments include founding Incept and Access Closure, creating over 1,600 jobs and generating over $1.5 billion in revenue. Amarpreet Sawhney’s investment check size varies depending on the company’s needs. He fosters entrepreneurship by mentoring innovators and creating companies through Incept, a medical device incubator.

Location: Bedford, MA

Country: India

Investment Regions: EA, NA

Investment Stages: pre-seed, seed

Website:

AI Reasoning: Search results show Amarpreet Sawhney invested in Axtria (Series A/C) with public records indicating an investment around 2015 (Crunchbase and related profiles). The most recent identified investment tied to him is from 2015, which is more than 12 months ago. Therefore classify as low-active.

Low Activity – Only known angel investments more than 12 months ago.

Active – Known angel investments between the last 12 and 6 months.

Very Active – Known angel investments in the last 6 months.